These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30270593)

  • 1. Clinical Response of Rifaximin Treatment in Patients with Abdominal Bloating.
    Yoon K; Kim N; Lee JY; Oh DH; Seo AY; Yun CY; Yoon H; Shin CM; Park YS; Lee DH
    Korean J Gastroenterol; 2018 Sep; 72(3):121-127. PubMed ID: 30270593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rifaximin therapy for patients with irritable bowel syndrome without constipation.
    Pimentel M; Lembo A; Chey WD; Zakko S; Ringel Y; Yu J; Mareya SM; Shaw AL; Bortey E; Forbes WP;
    N Engl J Med; 2011 Jan; 364(1):22-32. PubMed ID: 21208106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia.
    Tan VP; Liu KS; Lam FY; Hung IF; Yuen MF; Leung WK
    Aliment Pharmacol Ther; 2017 Mar; 45(6):767-776. PubMed ID: 28112426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the Management of Diarrhea-Predominant Irritable Bowel Syndrome: Focus on Rifaximin and Eluxadoline.
    Rivkin A; Rybalov S
    Pharmacotherapy; 2016 Mar; 36(3):300-16. PubMed ID: 26971716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: the treatment of functional abdominal bloating and distension.
    Schmulson M; Chang L
    Aliment Pharmacol Ther; 2011 May; 33(10):1071-86. PubMed ID: 21488913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of rifaximin therapy in patients with irritable bowel syndrome without constipation.
    Schey R; Rao SS
    Expert Rev Gastroenterol Hepatol; 2011 Aug; 5(4):461-4. PubMed ID: 21780893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence.
    Sharara AI; Aoun E; Abdul-Baki H; Mounzer R; Sidani S; Elhajj I
    Am J Gastroenterol; 2006 Feb; 101(2):326-33. PubMed ID: 16454838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months.
    Meyrat P; Safroneeva E; Schoepfer AM
    Aliment Pharmacol Ther; 2012 Dec; 36(11-12):1084-93. PubMed ID: 23066911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does rifaximin offer any promise in Crohn's disease in remission and concurrent irritable bowel syndrome-like symptoms?
    Tocia C; Dumitru IM; Alexandrescu L; Petcu LC; Dumitru E
    Medicine (Baltimore); 2021 Jan; 100(1):e24059. PubMed ID: 33429768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
    Liu ZJ; Wei H; Duan LP; Zhu SW; Zhang L; Wang K
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1896-902. PubMed ID: 27373356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Declining Rates of Referral for Irritable Bowel Syndrome Without Constipation at a Tertiary Care Center.
    Oh SJ; Tashjian VC; Mirocha J; Nagar M; Mathur R; Lin E; Chua KS; Rezaie A; Pimentel M; Pichetshote N
    Dig Dis Sci; 2019 Jan; 64(1):182-188. PubMed ID: 30324554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial.
    Pimentel M; Park S; Mirocha J; Kane SV; Kong Y
    Ann Intern Med; 2006 Oct; 145(8):557-63. PubMed ID: 17043337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectra, symptom profiles and overlap of Rome III functional gastrointestinal disorders in a tertiary center in South China.
    Xiong LS; Shi Q; Gong XR; Cui Y; Chen MH
    J Dig Dis; 2014 Oct; 15(10):538-44. PubMed ID: 25102919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of rifaximin, a nonabsorbed oral antibiotic, in the treatment of small intestinal bacterial overgrowth.
    Majewski M; Reddymasu SC; Sostarich S; Foran P; McCallum RW
    Am J Med Sci; 2007 May; 333(5):266-70. PubMed ID: 17505166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifaximin and eluxadoline - newly approved treatments for diarrhea-predominant irritable bowel syndrome: what is their role in clinical practice alongside alosetron?
    Cash BD; Lacy BE; Rao T; Earnest DL
    Expert Opin Pharmacother; 2016; 17(3):311-22. PubMed ID: 26559529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faecal retention: a common cause in functional bowel disorders, appendicitis and haemorrhoids--with medical and surgical therapy.
    Raahave D
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of linaclotide on severe abdominal symptoms in patients with irritable bowel syndrome with constipation.
    Rao SS; Quigley EM; Shiff SJ; Lavins BJ; Kurtz CB; MacDougall JE; Currie MG; Johnston JM
    Clin Gastroenterol Hepatol; 2014 Apr; 12(4):616-23. PubMed ID: 24075889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of rifaximin for the irritable bowel syndrome: a systematic review and meta-analysis.
    Menees SB; Maneerattannaporn M; Kim HM; Chey WD
    Am J Gastroenterol; 2012 Jan; 107(1):28-35; quiz 36. PubMed ID: 22045120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overlap between irritable bowel syndrome and functional dyspepsia including subtype analyses.
    Choi YJ; Kim N; Yoon H; Shin CM; Park YS; Kim JW; Kim YS; Lee DH; Jung HC
    J Gastroenterol Hepatol; 2017 Sep; 32(9):1553-1561. PubMed ID: 28160607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal calprotectin levels after rifaximin treatment in patients with irritable bowel syndrome with diarrhoea: A single-center prospective study.
    Safwat E; Salah M; Hussein H
    Arab J Gastroenterol; 2020 Dec; 21(4):273-277. PubMed ID: 32928705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.